(Q37524138)

English

Enhanced alpha-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications.

scientific article published on October 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Enhanced alpha-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1 reference

1 reference

2

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

author name string

Alison L McCormack

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

publication date

1 October 2009

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

published in

Current Protein and Peptide Science

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

volume

10

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

issue

5

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

page(s)

476-482

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Identifiers

DOI

10.2174/138920309789351912

1 reference

stated in

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

Europe PubMed Central

PubMed ID

19538156

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538156%20AND%20SRC:MED&resulttype=core&format=json

(Q37524138)

Enhanced alpha-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)